TEZRULY Drug Patent Profile
✉ Email this page to a colleague
When do Tezruly patents expire, and what generic alternatives are available?
Tezruly is a drug marketed by Novitium Pharma and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in TEZRULY is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tezruly
A generic version of TEZRULY was approved as terazosin hydrochloride by APNAR PHARMA LP on March 30th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TEZRULY?
- What are the global sales for TEZRULY?
- What is Average Wholesale Price for TEZRULY?
Summary for TEZRULY
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| What excipients (inactive ingredients) are in TEZRULY? | TEZRULY excipients list |
| DailyMed Link: | TEZRULY at DailyMed |
US Patents and Regulatory Information for TEZRULY
TEZRULY is protected by two US patents.
Patents protecting TEZRULY
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF HYPERTENSION IN PATIENTS WHO ARE IN NEED OF A LIQUID COMPOSITION OF TERAZOSIN
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH) IN PATIENTS WHO ARE IN NEED OF A LIQUID COMPOSITION OF TERAZOSIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novitium Pharma | TEZRULY | terazosin hydrochloride | SOLUTION;ORAL | 218139-001 | Jul 29, 2024 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
